Us Oral Solid Dose Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Oral Solid Dose Market was valued at USD 490 Billion in 2022 and is projected to reach USD 740 Billion by 2030, growing at a CAGR of 6% from 2024 to 2030.
The U.S. Oral Solid Dose (OSD) market is experiencing significant growth, driven by advancements in drug delivery technologies and strategic investments by Contract Development and Manufacturing Organizations (CDMOs). In 2022, the market was valued at approximately USD 10.20 billion and is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.1% from 2023 to 2030.
Tablets remain the most prevalent form within the OSD sector, accounting for a substantial share of the market. Their popularity stems from ease of administration, cost-effectiveness, and patient compliance. Capsules are also witnessing notable growth, with a projected CAGR of 6.44% over the forecast period, attributed to their advantages such as faster disintegration and absorption.
Immediate-release mechanisms dominate the market, holding over 50% share by value. These formulations are favored for their rapid onset of action, providing quick relief to patients. The demand for such formulations is expected to continue, expanding at a CAGR of 5.6% over the forecast period.
Large pharmaceutical companies are increasingly outsourcing OSD manufacturing to CDMOs, prioritizing quality, reliability, and productivity. This trend is evident as the large enterprises segment accounted for 54.8% of the market share in 2023. Collaborations between pharmaceutical giants and specialized CDMOs are enhancing production capacities and technological capabilities.
Several strategic initiatives have been undertaken to meet the growing demand. For instance, in May 2022, Catalent, Inc. announced a USD 175 million investment to expand its flagship manufacturing facility for large-scale oral dose forms in Winchester, Kentucky. Similarly, in January 2023, Aenova Group enhanced its capsule filling capacity at the Regensburg site by installing the state-of-the-art IMA Adapta 200 machine.
Despite the positive trajectory, the market faces challenges, particularly stringent regulatory compliance requirements. Navigating diverse and complex regulatory frameworks demands substantial resources, impacting operational efficiency and time-to-market. Manufacturers must invest significantly to adhere to international standards, which can influence both costs and timelines.
In summary, the U.S. Oral Solid Dose market is poised for robust growth, driven by technological advancements, strategic collaborations, and increasing outsourcing trends. However, addressing regulatory challenges remains crucial for sustained expansion in this dynamic sector.
Get an In-Depth Research Analysis of the Global Oral Solid Dose Market Size And Forecast [2025-2032]
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Oral Solid Dose Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Oral Solid Dose Market
Tablets
Capsules
Pills
Granules
Powders
Immediate Release
Extended Release
Delayed Release
Enteric Coated
Osmotic Release
Cardiovascular Agents
Antibiotics
Antidepressants
Analgesics
Oncology Drugs
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Institutional Pharmacies
Direct Distributors
Hospitals
Clinics
Pharmacies
Homecare Settings
Research and Academic Institutions
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Oral Solid Dose Market Research Analysis
1. Introduction of the Global Oral Solid Dose Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Oral Solid Dose Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Oral Solid Dose Market, By Type
6. Global Oral Solid Dose Market, By Application
7. Global Oral Solid Dose Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Oral Solid Dose Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/